Butterfly Network (BFLY) shares are in focus after the company reported second quarter 2026 results, which showed higher revenue, narrower losses year over year, and increased full year and third quarter revenue guidance.

Butterfly Network shares have pulled back over the past month, with a 30 day share price return of down 20.31%, although the 90 day share price return of 48.23% and 1 year total shareholder return of 292.27% still point to strong recent momentum.

If this earnings reaction has you looking across healthcare imaging and AI, it could be a good moment to scan the market using our screener for 41 healthcare AI stocks

Butterfly Network now appears to be a stronger business, supported by higher revenue and narrower losses. However, the share price has also moved sharply over the past year. Is the current valuation still reasonable?

Most Popular Narrative: 50% Overvalued

Butterfly Network last closed at $7.10 while the most followed narrative sets fair value at $7.06. That gap is small, yet the story behind it is anything but.

Commercialization of Butterfly Garden's clinical AI apps (e.g., HeartFocus, iCardio) expands the addressable market by enabling health professionals without prior ultrasound training to perform advanced diagnostics, catalyzing device sales, software adoption, and new recurring revenue streams, directly aligned with rising global demand for affordable, scalable healthcare solutions.

Want to see what sits under that growth story? The narrative leans on rapid revenue expansion, slimmer losses, and a rich future earnings multiple. The exact assumptions might surprise you.

Based on this narrative, Butterfly Network carries a fair value estimate of $7.06 that sits slightly below the latest close. That view is built on projected revenue growth, a shift from losses toward modest profitability, and a very high future P/E multiple applied to those forecast earnings, all discounted at 7.44% to reflect time and risk in the cash flows used.

Result: Fair Value of $7.06 (OVERVALUED)

However, Butterfly Network still faces real execution risks, including possible delays in large enterprise contracts and ongoing high R&D spending that could keep profitability out of reach for longer than analysts expect.

Next Steps

This mix of optimism and concern around Butterfly Network will not resolve itself. Look through the numbers, weigh both sides, and then review the 1 key reward and 2 important warning signs

Looking for more Butterfly Network style investment ideas?

If Butterfly Network has caught your attention, do not stop here. A few minutes with the Simply Wall Street Screener could uncover other opportunities that suit your approach.

• Target potential bargains with resilient fundamentals by scanning companies highlighted in the 49 high quality undervalued stocks.
• Zero in on stability first by checking stocks that appear in the 85 resilient stocks with low risk scores.
• Spot lesser known opportunities with strong quality markers by reviewing the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.